Byrnes Michael
Insider CIK 1619893 · OCRX VP, Finance & Treasurer · EFTR Chief Financial Officer · CERO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2026-01-07 | 2026-01-09 | 690,900 | — | $0 | 690,900 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-05-30 | 2025-06-02 | 9,326 | — | $0 | 9,326 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-03-04 | 2025-03-06 | 17,923 | — | $0 | 17,923 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-24 | 2025-02-26 | 127,500 | — | $0 | 255,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-12-02 | 2024-12-04 | 127,500 | — | $0 | 127,500 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2024-05-15 | 2024-05-17 | 1,387 | $1.68 | $2.3K | 3,117 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-03-25 | 2024-03-27 | 112,500 | — | $0 | 112,500 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-02-19 | 2024-02-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2023-11-15 | 2023-11-16 | 4,524 | $0.50 | $2.3K | 43,271 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2023-05-15 | 2023-05-16 | 4,863 | $0.46 | $2.2K | 38,747 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-01-17 | 2023-01-19 | 500,000 | — | $0 | 500,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2022-11-15 | 2022-11-16 | 4,651 | $0.47 | $2.2K | 33,884 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-06-20 | 2022-06-22 | 235,541 | — | $0 | 235,541 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | P Buy | 2022-06-07 | 2022-06-07 | 25,000 | $1.33 | $33.3K | 29,233 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2022-05-13 | 2022-05-17 | 4,233 | $1.53 | $6.5K | 4,233 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-01-20 | 2022-01-24 | 235,541 | — | $0 | 235,541 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 337,997 | — | $0 | 337,997 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 49,790 | — | $0 | 49,790 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 123,300 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 55,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 75,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 102,300 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 70,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 13,000 | $1.52 | $19.8K | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 150,000 | $1.52 | $228.0K | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award | 2017-03-29 | 2017-03-30 | 150,000 | — | $0 | 163,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2017-03-28 | 2017-03-28 | 3,000 | $1.28 | $3.8K | 13,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-16 | 102,300 | — | $0 | 102,300 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2016-01-15 | 2016-01-19 | 3,500 | $2.07 | $7.2K | 10,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-01-06 | 2016-01-07 | 41,100 | — | $0 | 41,100 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-01-06 | 2016-01-07 | 123,300 | — | $0 | 123,300 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2015-05-06 | 2015-05-06 | 2,500 | $3.61 | $9.0K | 6,500 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-12-02 | 2014-12-04 | 70,000 | — | $0 | 70,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2014-10-01 | 2014-10-02 | 2,000 | $4.81 | $9.6K | 4,000 | SEC↗ |